| Jason Jon Nakken, DO | |
|
3585 N University Ave Ste 105, Provo, UT 84604-6601 | |
| (801) 356-6100 | |
| Not Available |
| Full Name | Jason Jon Nakken |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 10 Years |
| Location | 3585 N University Ave Ste 105, Provo, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356755094 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverwoods Anesthesia Pllc | 0547217366 | 7 |
| Riverwood Spine And Pain Llc | 1153786355 | 3 |
News Archive
Opening day for any business is generally a nerve-wracking experience. Last-minute surprises are not uncommon. For Shonna Galloway, administrator for the brand-new Elizabethtown Diagnostic Imaging, however, the day before her employer's grand opening in October 2007 was one she'll never forget.
The intestinal microbiome is not only key for food processing but an accepted codeterminant for various diseases. Researchers led by the University Medical Center of Johannes Gutenberg University Mainz identified effects of nanoparticles on intestinal microorganisms.
BMA encouraged by vaccine ‘breakthrough' which brings ‘widespread protection a step closer'
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has completed enrollment in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.
› Verified 4 days ago
| Entity Name | Ut Center For Pain Management And Research, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902805948 PECOS PAC ID: 4587560693 Enrollment ID: O20031210000117 |
News Archive
Opening day for any business is generally a nerve-wracking experience. Last-minute surprises are not uncommon. For Shonna Galloway, administrator for the brand-new Elizabethtown Diagnostic Imaging, however, the day before her employer's grand opening in October 2007 was one she'll never forget.
The intestinal microbiome is not only key for food processing but an accepted codeterminant for various diseases. Researchers led by the University Medical Center of Johannes Gutenberg University Mainz identified effects of nanoparticles on intestinal microorganisms.
BMA encouraged by vaccine ‘breakthrough' which brings ‘widespread protection a step closer'
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has completed enrollment in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.
› Verified 4 days ago
| Entity Name | Riverwoods Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821290883 PECOS PAC ID: 0547217366 Enrollment ID: O20050405000096 |
News Archive
Opening day for any business is generally a nerve-wracking experience. Last-minute surprises are not uncommon. For Shonna Galloway, administrator for the brand-new Elizabethtown Diagnostic Imaging, however, the day before her employer's grand opening in October 2007 was one she'll never forget.
The intestinal microbiome is not only key for food processing but an accepted codeterminant for various diseases. Researchers led by the University Medical Center of Johannes Gutenberg University Mainz identified effects of nanoparticles on intestinal microorganisms.
BMA encouraged by vaccine ‘breakthrough' which brings ‘widespread protection a step closer'
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has completed enrollment in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.
› Verified 4 days ago
| Entity Name | Riverwood Spine & Pain Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881395085 PECOS PAC ID: 1153786355 Enrollment ID: O20230421001850 |
News Archive
Opening day for any business is generally a nerve-wracking experience. Last-minute surprises are not uncommon. For Shonna Galloway, administrator for the brand-new Elizabethtown Diagnostic Imaging, however, the day before her employer's grand opening in October 2007 was one she'll never forget.
The intestinal microbiome is not only key for food processing but an accepted codeterminant for various diseases. Researchers led by the University Medical Center of Johannes Gutenberg University Mainz identified effects of nanoparticles on intestinal microorganisms.
BMA encouraged by vaccine ‘breakthrough' which brings ‘widespread protection a step closer'
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has completed enrollment in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jason Jon Nakken, DO 3585 N University Ave Ste 105, Provo, UT 84604-6601 Ph: (801) 356-6100 | Jason Jon Nakken, DO 3585 N University Ave Ste 105, Provo, UT 84604-6601 Ph: (801) 356-6100 |
News Archive
Opening day for any business is generally a nerve-wracking experience. Last-minute surprises are not uncommon. For Shonna Galloway, administrator for the brand-new Elizabethtown Diagnostic Imaging, however, the day before her employer's grand opening in October 2007 was one she'll never forget.
The intestinal microbiome is not only key for food processing but an accepted codeterminant for various diseases. Researchers led by the University Medical Center of Johannes Gutenberg University Mainz identified effects of nanoparticles on intestinal microorganisms.
BMA encouraged by vaccine ‘breakthrough' which brings ‘widespread protection a step closer'
HemaQuest Pharmaceuticals, Inc., a biotechnology company focused on developing small molecule therapeutics to treat hemoglobin disorders, announced today that it has completed enrollment in a randomized multi-dose Phase 2 study of HQK-1001 in patients with sickle cell disease.
› Verified 4 days ago
Richard M Rosenthal, M.D. Pain Medicine Medicare: Medicare Enrolled Practice Location: 3585 N University Ave Ste 150, Provo, UT 84604 Phone: 801-356-6100 Fax: 801-356-2113 | |
Dr. Tao Li, MD Pain Medicine Medicare: Medicare Enrolled Practice Location: 3585 N University Ave, Ste #150, Provo, UT 84604 Phone: 801-356-6100 Fax: 801-356-2113 | |
Devan Partridge, DO Pain Medicine Medicare: Medicare Enrolled Practice Location: 1055 N 300 W Ste 316, Provo, UT 84604 Phone: 801-262-7246 | |
Dr. J Riley Stringham, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 280 River Park Dr, #200, Provo, UT 84604 Phone: 801-223-4860 Fax: 801-371-8993 |